Ipilimumab/nivolumabColitis: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2020年 / 1826卷 / 1期

关键词：

D O I：

10.1007/s40278-020-84632-7

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：185 / 185

相关论文

共 50 条

[41] NivolumabColitis: case report
Reactions Weekly, 2025, 2042 (1) : 388 - 388
[42] NivolumabColitis: case report
Reactions Weekly, 2017, 1665 (1) : 213 - 213
[43] NivolumabColitis: case report
Reactions Weekly, 2025, 2056 (1) : 426 - 426
[44] NivolumabColitis and pancreatitis: case report
Reactions Weekly, 2022, 1913 (1) : 353 - 353
[45] Ipilimumab/nivolumab/nivolumabColitis and lack of efficacy
Reactions Weekly, 2024, 2005 (1) : 469 - 469
[46] NivolumabColitis and diarrhoea: case report
Reactions Weekly, 2022, 1932 (1) : 473 - 473
[47] NivolumabColitis and steatonecrotic hepatitis: case report
Reactions Weekly, 2017, 1638 (1) : 171 - 171
[48] Ipilimumab/nivolumabColitis, hepatotoxicity and immune-related encephalitis: 3 case reports
Reactions Weekly, 2021, 1853 (1) : 256 - 256
[49] NivolumabColitis and large-duct cholangiopathy: case report
Reactions Weekly, 2020, 1789 (1) : 193 - 193
[50] Interferon-alpha/ipilimumab/nivolumabColitis, granulomatous lymphadenitis and psychosis: 3 case reports
Reactions Weekly, 2023, 1939 (1) : 254 - 254

← 1 2 3 4 5 →